fibrosis and, consequently, ventricular dysfunction.
Up to now, numerous studies have provided a large variety of potential effects attributed to highly unsaturated fatty acid (HUFA) treatment ranging from marked prognostic improvements in heart failure and antiarrhythmogenic actions to no incremental effects.
Due to the divergent results, the question arises whether mechanisms exist beyond an external HUFA intake.
In heart failure, an inverse shift of serum fatty acids occurs; particularly saturated and monounsaturated fatty acids were increased, whereas poly-and highly unsaturated omega-6 and omega-3 fatty acids were decreased (2, 3) . We have recently shown that increased ventricular wall stress is associated with reduced DHA levels (unpublished data, P. Alter, January, 2015). Similar, but less pronounced effects were found for eicosapentae- 
